title: Flag Leaf 3

description:
Flag Leaf vs. Cultured Cell (control sample)
Keywords = rice
Keywords = flag leaf

source_name: Flag leafs from heading stage (Cy5)


title: Parental H4 vs. Mutant H4 K8R (2)

status: Public on Mar 05 2005

type: RNA

city: Worcester

first: Oliver

last: Rando

state: MA

address: 364 Plantation St.

country: USA

institute: UMass Medical School

description: Parental H4 vs. Mutant H4 K8R (2)

molecule: total RNA

organism: Saccharomyces cerevisiae


title: Seedling Shoot 2

city: Pasadena

first: Yuling

last: Jiao

state: CA

address: 1200 E California Blvd

department: Biology

institute: California Institute of Technology

description:
Seedling Shoot vs. Cultured Cell (control sample)
Keywords = rice
Keywords = shoot

organism: Oryza sativa

source_name: Shoots from seeding stage (Cy5)

source_name: Cultured Cells (Cy3)


title: Parental H4 vs. Mutant H4 K5, 8, 12, 16R (11)


title: Flag Leaf 2


title: Parental H4 vs. Mutant H4 K5, 12, 16R (1) (biol. repl. 3, tech. repl. 2)


title: Panicle 2

description:
Panicle vs. Cultured Cell (control sample)
Keywords = rice
Keywords = panicle

source_name: Panicles from heading stage (Cy5)


title: Panicle 1


title: Flag Leaf 1


title: Parental H4 vs. Mutant H4 K5, 8, 12, 16R (11) (tech. repl. 2)


title: Parental H4 vs. Mutant H4 K8, 12R (2) (biol. repl. 3)


title: Parental H4 vs. Mutant H4 K5, 8R (2)

description: Parental H4 vs. Mutant H4 K5, 8R (2)


title: Parental H4 vs. Mutant H4 K16R (2)

description: Parental H4 vs. Mutant H4 K16R (2)


title: Parental H4 vs. Mutant H4 K5, 16R (2)

description: Parental H4 vs. Mutant H4 K5, 16R (2)


title: Parental H4 vs. Mutant H4 K5, 12R (2)

description: Parental H4 vs. Mutant H4 K5, 12R (2)


title: Parental H4 vs. Mutant H4 K12R (2)

description: Parental H4 vs. Mutant H4 K12R (2)


title: Parental H4 vs. Mutant H4 K8, 12R (2)

description: Parental H4 vs. Mutant H4 K8, 12R (2)


title: Parental H4 vs. Mutant H4 K8, 16R (2)

description: Parental H4 vs. Mutant H4 K8, 16R (2)


title: Parental H4 vs. Mutant H4 K8, 16R

description: Parental H4 vs. Mutant H4 K8, 16R


title: Parental H4 vs. Mutant H4 K5, 16R

description: Parental H4 vs. Mutant H4 K5, 16R


title: Parental H4 vs. Mutant H4 K5, 12, 16R (biol. repl. 2)


title: Parental H4 vs. Mutant H4 K12R

description: Parental H4 vs. Mutant H4 K12R


title: Parental H4 vs. Mutant H4 K8, 12, 16R (biol. repl. 2)


title: Parental H4 vs. Mutant H4 K12, 16R

description: Parental H4 vs. Mutant H4 K12, 16R


title: Parental H4 vs. Mutant H4 K5R

description: Parental H4 vs. Mutant H4 K5R


title: Parental H4 vs. Mutant H4 K5, 8, 12R (biol. repl. 2)


title: Parental H4 vs. Mutant H4 K8, 12, 16R

description: Parental H4 vs. Mutant H4 K8, 12, 16R


title: Parental H4 vs. Mutant H4 K5, 12R (s)

description: Parental H4 vs. Mutant H4 K5, 12R (s)


title: Parental H4 vs. Mutant H4 K5, 8R (s)

description: Parental H4 vs. Mutant H4 K5, 8R (s)


title: Parental H4 vs. Mutant H4 K5, 12, 16R

description: Parental H4 vs. Mutant H4 K5, 12, 16R


title: Parental H4 vs. Mutant H4 K5, 8, 16R

description: Parental H4 vs. Mutant H4 K5, 8, 16R


title: Parental H4 vs. Mutant H4 K8, 16R (s)

description: Parental H4 vs. Mutant H4 K8, 16R (s)


title: Parental H4 vs. Mutant H4 K5R (2)

description: Parental H4 vs. Mutant H4 K5R (2)


title: Parental H4 vs. Mutant H4 K5R (s)

description: Parental H4 vs. Mutant H4 K5R (s)


title: Parental H4 vs. Mutant H4 K16R

description: Parental H4 vs. Mutant H4 K16R


title: Parental H4 vs. Mutant H4 K5, 16R (s)

description: Parental H4 vs. Mutant H4 K5, 16R (s)


title: Parental H4 vs. Mutant H4 K5, 8R

description: Parental H4 vs. Mutant H4 K5, 8R


title: Parental H4 vs. Mutant H4 K12R (s)

description: Parental H4 vs. Mutant H4 K12R (s)


title: 3D7-2-08hr

status: Public on Mar 08 2005

city: Parkville

first: Ken

last: Simpson

state: Victoria

address: 1G Royal Parade

department: Genetics and Bioinformatics

country: Australia

institute: The Walter and Eliza Hall Institute

description:
3D7 wildtype, replicate 2
Keywords = SIR2
Keywords = epigenetic regulation
Keywords = antigenic variation
Keywords = var
Keywords = Plasmodium falciparum

organism: Plasmodium falciparum

source_name: wildtype 3D7 parasites, ring stage, 8hrs post-invasion


title: Parental H4 vs. Mutant H4 K12, 16R (s)

description: Parental H4 vs. Mutant H4 K12, 16R (s)


title: Parental H4 vs. Mutant H4 K5, 8, 12R (s)


title: Parental H4 vs. Mutant H4 K8R (s)

description: Parental H4 vs. Mutant H4 K8R (s)


title: Parental H4 vs. Mutant H4 K8, 16R (2) (biol. repl. 2)


title: Parental H4 vs. Mutant H4 K5, 8, 12R

description: Parental H4 vs. Mutant H4 K5, 8, 12R


title: Parental H4 vs. Mutant H4 K8, 12, 16R (s)


title: Parental H4 vs. Mutant H4 K12, 16R (2)

description: Parental H4 vs. Mutant H4 K12, 16R (2)


title: Parental H4 vs. Mutant H4 K8, 12, 16R (2)


title: Parental H4 vs. Mutant H4 K5, 8R (2) (biol. repl. 2)


title: Parental H4 vs. Mutant H4 K8, 12R (2) (biol. repl. 2)


title: Parental H4 vs. Mutant H4 K5, 12, 16R (s)


title: Parental H4 vs. Mutant H4 K5, 12R (2) (biol. repl. 2)


title: Parental H4 vs. Mutant H4 K5, 8, 12, 16R


title: Parental H4 vs. Mutant H4 K5, 8, 12R (2)


title: Day35_1B

status: Public on Mar 04 2005

city: Zürich

first: Christoph

last: Huber

country: Switzerland

institute: Neuropathology

description: mesenteric lymph node of mice treated with soluble lymphotoxin-beta receptor for 35 Days

organism: Mus musculus

source_name: mesenteric lymph node


title: Parental H4 vs. Mutant H4 K5, 8, 12, 16R (2)


title: Parental H4 vs. Mutant H4 K5, 8, 16R (2)


title: Parental H4 vs. Mutant H4 K12, 16R (biol. repl. 2)


title: Day3_3B

description: mesenteric lymph node of mice treated with soluble lymphotoxin-beta receptor for 3 Days


title: Day27_1B

description: mesenteric lymph node of mice treated with soluble lymphotoxin-beta receptor for 27 Days


title: Day27_2B


title: Day27_3B


title: Parental H4 vs. Mutant H4 K5, 8, 12R (biol. repl. 3)


title: Day3_1B


title: Day35_3B


title: Day2_3B

description: mesenteric lymph node of mice treated with soluble lymphotoxin-beta receptor for 2 Days


title: Day3_2B


title: Day1_2B

description: mesenteric lymph node of mice treated with soluble lymphotoxin-beta receptor for 1 Day


title: Day2_1B


title: Day2_2B


title: High Leu, 30 min, second experiment

status: Public on Mar 11 2005

city: Jacksonville

first: Yan

middle: W.

last: Asmann

state: FL

address: 4500 San Pablo Road South

institute: Mayo Clinic

description: Cells in 2.0 mM Leu

organism: Homo sapiens

source_name: Human Liver Cell Line THLE-3


title: Day1_1B

source_name: absolute detection call


title: Day0_3B

description: mesenteric lymph node of mice treated with PBS


title: Parental H4 vs. Mutant H4 K8R

description: Parental H4 vs. Mutant H4 K8R


title: Day1_3B


title: Day0_2B


title: Day27_2


title: Day35_1


title: FDC-E1C

description: isolated primary splenocytes enriched for follicular dendritic cells

source_name: Folliculard dendritic cell-enriched splenocytes


title: Day35_3


title: Day35_2


title: Day27_1


title: Parental H4 vs. Mutant H4 K5, 16R (2) (biol. repl. 2)


title: Day35_2B


title: FDC-D2C

description: isolated primary splenocytes depleted of follicular dendritic cells

source_name: Folliculard dendritic cell-depleted splenocytes


title: FDC-E2C


title: Day3_2


title: Day27_3


title: FDC-E3C


title: Seedling Shoot 3


title: Day3_3


title: Day0_1B


title: Day2_3


title: FDC-D2B


title: FDC-E3B


title: Day2_2


title: FDC-D1C


title: FDC-E3A


title: Day2_1


title: Day1_3


title: FDC-E2B


title: FDC-D1B


title: Day0_3

description: mesenteric lymph node treated with PBS


title: Day1_1


title: FDC-E2A


title: HEK293T cells, forskolin 1hr 2

status: Public on Mar 02 2005

city: La Jolla

first: Xinmin

last: Zhang

address: 10010 N. Torrey Pines Rd.

institute: Salk Institute

description:
Culture of human HEK293T cells, treated with forskolin for 0hr, 1hr and 4 hr. RNA was extracted using the Qiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA.  Duplicates for each time point is used.  Data was analyzed using dChIP software (www.dchip.org).
Keywords = HEK293T, cAMP induced genes, forskolin, CREB target genes

source_name: Human HEK293T cell line


title: FDC-D2A


title: FDC-E1A


title: Day0_1

description: mesenteric lymph node treated with PBS


title: FDC-D1A


title: Human Pancreatic islet, Forskolin treated 2

description:
Primary culture of human pancreatic islet,with 1 hr forskolin (a cAMP agonist) treatment. RNA was extracted using the Qiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA.  2 control and 2 forskolin treated samples were analyzed. Data was analyzed using dChIP software (www.dchip.org).
Keywords = Pancreatic islet
Keywords = cAMP induced genes
Keywords = forskolin
Keywords = CREB target genes

source_name: Human Pancreatic islet


title: Human Pancreatic islet, untreated 2

description:
Primary culture of human pancreatic islet,no treatment (as compared to forskolin treated samples). RNA was extracted using the Qiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA.  2 control and 2 forskolin treated samples were analyzed. Data was analyzed using dChIP software (www.dchip.org).
Keywords = Pancreatic islet
Keywords = cAMP induced genes
Keywords = forskolin
Keywords = CREB target genes


title: Human Pancreatic islet, Forskolin treated 1

description:
Primary culture of human pancreaticeislet,with 1 hr forskolin (a cAMP agonist) treatment. RNA was extracted using the Qiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA.  2 control and 2 forskolin treated samples were analyzed. Data was analyzed using dChIP software (www.dchip.org).
Keywords = Pancreatic islet
Keywords = cAMP induced genes
Keywords = forskolin
Keywords = CREB target genes


title: Day0_2

description: mesenteric lymph node treated with PBS


title: HEK293T cells, forskolin 4hr 1


title: MIN6 cell, ACREB Forskolin 2

description:
Culture of mouse MIN6 cells, infected with ACREB adenovirus, with 1hr forskolin (a cAMP agonist) treatment. ACREB is a dominant negative form of the CREB protein. RNA was extracted using the Qiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA.  2 control and 2 forskolin treated samples from GFP virus infected cells, and 2 forskolin treated samples from ACREB virus infected cells were analyzed. Data was analyzed using dChIP software (www.dchip.org).
Keywords = MIN6, cAMP induced genes, forskolin, CREB target genes

source_name: Mouse pancreatic beta cell line MIN6


title: HEK293T cells, forskolin 0hr 2


title: HEK293T cells, forskolin 0hr 1


title: Human Pancreatic islet, untreated 1


title: HEK293T cells, forskolin 1hr 1


title: Day3_1


title: MIN6 cell, GFP Forskolin 2

description:
Culture of mouse MIN6 cells, infected with GFP control adenovirus, with 1hr forskolin (a cAMP agonist) treatment. RNA was extracted using the Qiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA.  2 control and 2 forskolin treated samples from GFP virus infected cells, and 2 forskolin treated samples from ACREB virus infected cells were analyzed. Data was analyzed using dChIP software (www.dchip.org).
Keywords = MIN6, cAMP induced genes, forskolin, CREB target genes


title: MIN6 cell, ACREB Forskolin 1


title: HEK293T cells, Forskolin 2

description:
Culture of human HEK293T cells, with 1hr forskolin (a cAMP agonist) treatment. RNA was extracted using the Qiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA.  2 control and 2 forskolin treated samples, and 2 forskolin treated samples from ACREB transfected cells were analyzed. Data was analyzed using dChIP software (www.dchip.org).
Keywords = HEK293T, cAMP induced genes, forskolin, CREB target genes


title: HEK293T cells, ACREB Forskolin 1

description:
Culture of human HEK293T cells, transfected with ACREB, a dominant negative form of the CREB protein, and treated with 1hr forskolin (a cAMP agonist). RNA was extracted using the Qiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA.  2 control and 2 forskolin treated samples, and 2 forskolin treated samples from ACREB transfected cells were analyzed. Data was analyzed using dChIP software (www.dchip.org).
Keywords = HEK293T, cAMP induced genes, forskolin, CREB target genes


title: HEK293T cells, control 1

description:
Culture of human HEK293T cells, no treatment (as compared to forskolin treated samples). RNA was extracted using the Qiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA.  2 control and 2 forskolin treated samples, and 2 forskolin treated samples from ACREB transfected cells were analyzed. Data was analyzed using dChIP software (www.dchip.org).
Keywords = HEK293T, cAMP induced genes, forskolin, CREB target genes


title: HEK293T cells, Forskolin 1


title: MIN6 cell, GFP Forskolin 1


title: HEK293T cells, control 2


title: Pmel stim 1 vs. pmel stim 2, repeat

city: Bethesda

first: Keith

last: Kerstann

state: MD

department: Surgery Branch

institute: National Institutes of Health

description: Comparison of murine effector T cells from  a transgenic pmel mouse following one and two rounds of in vitro restimulation.

source_name: pmel CD8+ post stim 1

source_name: pmel CD8+ post stim 2


title: HEK293T cells, ACREB Forskolin 2


title: CB-AE.2

status: Public on Mar 01 2005

city: New York

first: Agnes

last: Viale

state: NY

address: 1275 York Avenue

department: Molecular Biology

institute: Memorial Sloan Kettering Cancer Center

description:
AML1-ETO Transduced CD 34 cells- not selected after transduction
Keywords = AML1-ETO

source_name: Total RNA


title: MIN6 cell, GFP control 2

description:
Culture of mouse MIN6 cells, infected with GFP control adenovirus, no treatment (as compared to forskolin treated samples). RNA was extracted using the Qiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA.  2 control and 2 forskolin treated samples from GFP virus infected cells, and 2 forskolin treated samples from ACREB virus infected cells were analyzed. Data was analyzed using dChIP software (www.dchip.org).
Keywords = MIN6, cAMP induced genes, forskolin, CREB target genes


title: Parental H4 vs. Mutant H4 K5, 8, 16R (s)


title: Pmel stim 1 vs. pmel stim 2


title: Untreated Exp1

city: New Haven

first: Daniel

middle: B

last: Stetson

state: CT

address: 300 Cedar Street

department: Immunobiology

institute: Yale University

description: Bone marrow-derived dendritic cells were left untreated as a control

source_name: Dendritic cells


title: CpG Exp.1

description: Bone marrow-derived dendritic cells were treated for four hours with 3 uM CpG DNA.


title: 05_30_03_hela

city: San Francisco

first: Joe

last: DeRisi

department: Biochemistry and Biophysics

institute: University of California, San Francisco

description: Amplified HeLa RNA

organism: Viruses

source_name: HeLa cells


title: ISD Exp2

description: Bone marrow-derived dendritic cells were treated with lipid-transfected DNA for four hours


title: ISD Exp.1

description: Bone marrow-derived dendritic cells were treated for four hours with lipid-transfected double-stranded DNA.

source_name: Dendritic Cells


title: CpG Exp2

description: Bone marrow-derived dendritic cells were treated with 3uM CpG DNA for four hours


title: Untreated Exp2

description: Bone marrow-derived dendritic cells were left untreated as controls


title: 02_06_04_383ped

description: Amplified RNA from nasal lavage. This sample was positive for Influenza A virus by DFA.

source_name: Nasal lavage


title: 04_11_03_hela

description: Amplified HeLa RNA


title: CB-MIGR1.2

description:
MIGR1 Transduced CD 34 cells- not selected after transduction
Keywords = MIGR1


title: 04_11_03_217ped

description: Amplified RNA from nasal lavage. This sample was positive for Respiratory Syncytial virus by DFA.


title: 04_07_04_HRV83

description: Amplified RNA from Human rhinovirus 83

source_name: HRV83 culture


title: 04_07_04_HRV65

description: Amplified RNA from Human rhinovirus 65

source_name: HRV65 culture


title: 02_06_04_369ped


title: 11_12_03_254ped


title: 03_31_04_HRV61

description: Amplified RNA from Human rhinovirus 61

source_name: HRV61 culture


title: 01_30_04_HRV45

description: Amplified RNA from Human rhinovirus 45

source_name: HRV45 culture


title: 01_29_04_hela

description: Amplified HeLa RNA


title: 12_05_03_hela

description: Amplified HeLa RNA


title: 12_08_03_HRV87

description: Amplified RNA from Human rhinovirus 87

source_name: HRV87 culture


title: 01_30_04_HRV39

description: Amplified RNA from Human rhinovirus 39

source_name: HRV39 culture


title: HEK293T cells, forskolin 4hr 2

description:
Culture of human HEK293T cells, treated with forskolin for 0hr, 1hr and 4 hr. RNA was extracted using the Qiagen RNeasy kit. Targets were produced using standard Affymetrix procedures from about 5ug of total RNA.  Duplicates for each time point is used.  Data was analyzed using dChIP software (www.dchip.org).
Keywords = HEK293T, cAMP induced genes, forskolin, CREB target genes


title: 03_31_04_HRV27

description: Amplified RNA from Human rhinovirus 27

source_name: HRV27 culture


title: 03_31_04_HRV12

description: Amplified RNA from Human rhinovirus 12

source_name: HRV12 culture


title: 02_12_04_367ped

description: Amplified RNA from nasal lavage. This sample was positive for Influenza A virus by DFA and for Respiratory Syncytial virus by PCR.


title: 03_31_04_HRV33

description: Amplified RNA from Human rhinovirus 33

source_name: HRV33 culture


title: 11_05_03_68ped


title: 01_22_04_hela

description: Amplified HeLa RNA


title: 11_14_03_100ped


title: 02_12_04_357ped


title: 10_08_03_hela

description: Amplified HeLa RNA


title: 11_12_03_hela

description: Amplified HeLa RNA


title: 02_28_03_hela

description: Amplified HeLa RNA


title: 04_10_04_HRV10

description: Amplified RNA from Human rhinovirus 10

source_name: HRV10 culture


title: 05_07_03_140ped


title: 12_12_03_hela

description: Amplified HeLa RNA


title: 04_10_04_HRV22

description: Amplified RNA from Human rhinovirus 22

source_name: HRV22 culture


title: MIN6 cell, GFP control 1

source_name: Mouse pancreatic beta cell line MIN6


title: 06_23_04_hela

description: Amplified HeLa RNA


title: 02_12_04_348ped


title: 04_16_03_108ped


title: 04_07_04_HRV80

description: Amplified RNA from Human rhinovirus 80

source_name: HRV80 culture


title: 04_07_04_HRV70

description: Amplified RNA from Human rhinovirus 70

source_name: HRV70 culture


title: 60 min PTH treatment, replicate b

city: Little Rock

first: Xiao-Dong

last: Chen

state: AR

institute: University of Arkansas for Medical Sciences

description: Second triplicate of 60 min PTH treatment group

source_name: 60 min


title: Day1_2

description: mesenteric lymph node of mice treated with soluble lymphotoxin-beta receptor for 1 Day

source_name: mesenteric lymph node


title: 04_07_04_HRV4

description: Amplified RNA from Human rhinovirus 4

source_name: HRV4 culture


title: 06_23_04_130ped

source_name: Nasal lavage


title: 60 min PTH treatment, replicate c

description: Third triplicate of 60 min PTH treatment group


title: 06_11_04_130ped


title: 03_31_04_HRV8

description: Amplified RNA from Human rhinovirus 8

source_name: HRV8 culture


title: 5_31_03_1820Hep

description: Amplified RNA from serum. This sample was positive for Hepatitis B virus by PCR.

source_name: Serum


title: 06_11_04_hela

description: Amplified HeLa RNA

source_name: HeLa cells


title: 12_08_03_HRV11

description: Amplified RNA from Human rhinovirus 11

source_name: HRV11 culture


title: 11_21_03_115ped


title: 11_21_03_114ped


title: 04_10_04_HRV60

description: Amplified RNA from Human rhinovirus 60

source_name: HRV60 culture


title: 30 min PTH treatment, replicate c

description: Third triplicate of 30 min PTH treatment group

source_name: 30 min


title: 0 min PTH treatment, replicate c

description: Third triplicate of basal level group

source_name: 0 min


title: 0 min PTH treatment, replicate b

description: Second triplicate of basal level group


title: 60 min PTH treatment, replicate a

description: First triplicate of 60 min PTH treatment group


title: 30 min PTH treatment, replicate a

description: First triplicate of 30 min PTH treatment group


title: 02_12_04_hela

description: Amplified HeLa RNA


title: 30 min PTH treatment, replicate b

description: Second triplicate of 30 min PTH treatment group


title: 06_13_03_211ped


title: 0 min PTH treatment, replicate a

description: First triplicate of basal level group


title: 04_10_04_HRV29

description: Amplified RNA from Human rhinovirus 29

source_name: HRV29 culture


title: 11_05_03_113ped


title: 02_12_04_391ped


title: 04_10_04_HRV55

description: Amplified RNA from Human rhinovirus 55

source_name: HRV55 culture


title: 04_10_04_HRV28

description: Amplified RNA from Human rhinovirus 28

source_name: HRV28 culture


title: (ratio profile 2 -pol) LAT3YF CD5+ gamma delta T cells vs. wildtype CD5+ gamma delta T cells

city: Berlin

first: Hans-Joachim

last: Mollenkopf

address: Charitéplatz 1

country: Germany

institute: Max-Planck-Institute for Infection Biology

description:
ratio profile (dye-reversal: -polarity)
CD5+ gamma delta T cells were positively sorted (FACSDiva) from wildtype or from Lat3YF spleens using MACS and anti-CD5 beads

source_name: LAT3YF CD5+ gamma delta T cells

source_name: wildtype CD5+ gamma delta T cells


title: (ratio profile 2 -pol)  LATY136F CD4+ alpha beta T cells vs. wildtype CD4+ alpha beta T cells

description:
ratio profile (dye-reversal: -polarity)
CD4+ alpha beta T cells were positively sorted (FACSDiva) from wildtype or from LatY136F spleens using MACS and anti-CD4 beads

source_name: LATY136F CD4+ alpha beta T cells

source_name: wildtype CD4+ alpha beta T cells


title: 12_19_03_hela

description: Amplified HeLa RNA


title: 10_07_03_HRV16

description: Amplified RNA from Human rhinovirus 16

source_name: HRV16 culture


title: (ratio profile 1 +pol) wildtype CD5+ gamma delta T cells vs. LAT3YF CD5+ gamma delta T cells

description:
ratio profile (dye-reversal: +polarity)
CD5+ gamma delta T cells were positively sorted (FACSDiva) from wildtype or from Lat3YF spleens using MACS and anti-CD5 beads


title: 05_09_03_hela

description: Amplified HeLa RNA


title: 10_07_03_HRV26

description: Amplified RNA from Human rhinovirus 26

source_name: HRV26 cutlure


title: Zn2

status: Public on Feb 28 2005

city: Durham

first: Yuh-Chin

middle: Tony

last: Huang

state: NC

address: Erwin Rd

department: Medicine

institute: Duke University Medical Center

description: Human bronchial epithelial cells were treated with ZnSO4 (Zn, 50 uM) for 4 hours

source_name: Primary human Bronchial epithelial cells


title: 07_18_03_hela

description: Amplified HeLa RNA


title: Zn3


title: Zn4


title: V4

description: Human bronchial epithelial cells were treated with VOSO4 (V, 50 uM) for 4 hours


title: (ratio profile 1 +pol) wildtype CD4+ alpha beta T cells vs. LATY136F CD4+ alpha beta T cells

description:
ratio profile (dye-reversal: +polarity)
CD4+ alpha beta T cells were positively sorted (FACSDiva) from wildtype or from LatY136F spleens using MACS and anti-CD4 beads


title: FEEDER - Feeder Cell Layer from Fetal Liver

first: Sunil

last: Kurian

address: 10550 N Torrey Pines Road

department: Molecular and Experimental Medicine

institute: The Scripps Research Institute

description: While others have reported that fetal liver contains a population of endothelial progenitors based on expression of cell surface markers or culture assays, this is the first proof of a CD31+Sca1+ progenitor by demonstrating highly efficient in vivo angiogenesis and a direct connection to the host vasculature. We have developed a novel isolation method based on collagenase digestion and culture on a fetal liver-derived feeder layer and demonstrate that the feeder cells or their supernatants are required for endothelial progenitor survival and proliferation. Proteogenomic profiling of the endothelial progenitors and the feeder cells was done with tandem mass spectrometry proteomics using MudPIT and gene transcript expression profiling using high density DNA microarrays. This approach identified a number of gene transcripts, proteins and candidate growth factor pathways that are likely to be involved in endothelial progenitor growth, differentiation and angiogenesis.

source_name: Fetal Liver


title: Zn1


title: V1


title: Control4

description: Human bronchial epithelial cells were treated with vehicle for 4 hours


title: V2


title: V3


title: Sample_E

city: Berkely

first: Sanchita

last: Bhattacharya

address: 1 Cyclotron Rd

institute: MIT

description: Gene Expression profiles of E.coli grown in LB and Minimal medium (DM) at OD 600 =1

organism: Escherichia coli

source_name: LB medium

source_name: DM medium


title: Syngen

city: Innsbruck

middle: Alexander

last: Wrulich

address: Fritz Pregl Strasse 3

country: Austria

institute: Institute of Medical Chemistry and Biochemistry

description: mice untreated syngeneic control

source_name: cardiac syngraft


title: Sample_A


title: Sample_C


description: mice treated with N-imino ethyl-L-lysine (5mg/kg every 8 hrs)

source_name: cardiac allograft


title: ABH4

description: mice treated with 4-amino tetrahydrobiopterin (50mg/kg every 8 hrs)


title: Control2


title: dot4ubp8 null vs wt set2

status: Public on Feb 25 2005

city: Seattle

last: Gottschling

state: WA

address: 1100 Fairview Avenue N., Mailstop A3-025

department: Division of Basic Sciences

institute: Fred Hutchinson Cancer Research Center

description: Cy5/Cy3 comparison of dot4ubp8/DOT4UBP8 cells grown in YEPD

source_name: UCC6393(dot4ubp8 null)


title: ubp8 null vs wt set3

description: Cy5/Cy3 comparison of ubp8/UBP8 cells grown in YEPD

source_name: UCC6392(ubp8 null)


title: BH4

description:
mice treated with
tetrahydrobiopterin (50mg/kg every 8 hrs)


title: CsA

description: mice treated with cyclosporin A (15mg/kg every 24 hrs)


title: ubp8 null vs wt set1


title: dot4ubp8 null vs wt set3


title: Allogen

description: mice untreated allograft control


title: Control1


title: dot4 null vs wt set3

description: Cy5/Cy3 comparison of dot4/DOT4 cells grown in YEPD

source_name: UCC6390(dot4 null)


title: dot4 null vs wt set1


title: dot4ubp8 null vs wt set1


title: Control3


title: wt vs dot4 null set3

description: Cy5/Cy3 comparison of DOT4/dot4 cells grown in YEPD


title: wt vs dot4ubp8 null set3

description: Cy5/Cy3 comparison of DOT4UBP8/dot4ubp8 cells grown in YEPD

source_name: UCC6392(dot4ubp8 null)


title: ubp8 null vs wt set2


title: wt vs ubp8 null set3

description: Cy5/Cy3 comparison of UBP8/ubp8 cells grown in YEPD


title: dot4 null vs wt set2


title: wt vs ubp8 null set2


title: wt vs ubp8 null set1


title: wt vs dot4 null set2


title: wt vs dot4 null set1


title: wt vs dot4ubp8 null set2


title: wt vs dot4ubp8 null set1


title: pool of b6, b8, b9

city: Madison

first: Christina

last: Kendziorski

state: WI

address: 1300 University Avenue (6729 MSC)

department: Biostatistics and Medical Informatics

institute: University of Wisconsin

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b6, b8 and b9 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control

organism: Rattus norvegicus

source_name: pooled mammary glands (Female Wistar Furth Rat)


title: aliquot bq, technical rep3

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from the 12 individual rats in group b to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control

source_name: individual rat mammary gland (Female Wistar Furth Rat)


title: individual rat b6

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b6 in diestrus.
a is RXR treatment, b is control


title: individual rat b9

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b9 in diestrus.
a is RXR treatment, b is control


title: aliquot bq, technical rep2


title: pool of 12 b-individual rats (aliquot bq)


title: aliquot bq, technical rep1


title: pool of b8, b9

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b8 and b9 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: individual rat b13

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b13 in diestrus.
a is RXR treatment, b is control


title: individual rat b3, technical rep1

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: individual rat b5

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b5 in diestrus.
a is RXR treatment, b is control


title: individual rat b2

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b2 in diestrus.
a is RXR treatment, b is control


title: pool of b2, b3

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b2 and b3 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: individual rat b8

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b8 in proestrus or estrus.
a is RXR treatment, b is control


title: individual rat b15

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b15 in diestrus.
a is RXR treatment, b is control


title: individual rat b3, technical rep2


title: pool of b13, b15

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b13 and b15 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: individual rat b14

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b14 in diestrus.
a is RXR treatment, b is control


title: pool of b5, b6

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b5 and b6 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: pool of b2, b3, b5

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b2, b3 and b5 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: individual rat b3

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b3 in estrus.
a is RXR treatment, b is control


title: pool of b12, b14, b15

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b12, b14 and b15 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: pool of b10, b11

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b10 and b11 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: individual rat b11

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b11 in diestrus.
a is RXR treatment, b is control


title: pool of b12, b14

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b12 and b14 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: individual rat b12

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b12 in diestrus.
a is RXR treatment, b is control


title: T_DU_EXP3_DUPLICATE2

city: Knoxville

first: Bin

last: Wan

state: TN

institute: University of Tennessee, Knoxville

description: purified DO11.10 mice splenic CD4+ T-cells with 100uM DU treatment in anti-CD3 coated 96 well for 24 hrs. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the third experiment, duplicate spot#2.

source_name: Primary CD4+ T-cell, 100uM DU treatment, 24h


title: individual rat b10

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat b10 in estrus.
a is RXR treatment, b is control


title: T_DU_EXP3_DUPLICATE1

description: purified DO11.10 mice splenic CD4+ T-cells with 100uM DU treatment in anti-CD3 coated 96 well for 24 hrs. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the third experiment, duplicate spot#1.


title: aliquot aq, technical rep2

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from the 12 individual rats in group a to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: aliquot aq, technical rep3


title: pool of b10, b11, b13

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats b10, b11, and b13 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: T_DU_EXP1_DUPLICATE1

description: purified DO11.10 mice splenic CD4+ T-cells with 100uM DU treatment in anti-CD3 coated 96 well for 24 hrs. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the first experiment, duplicate spot#1.


title: T_CON_EXP3_DUPLICATE2

description: purified DO11.10 mice splenic CD4+ T-cells without DU treatment in anti-CD3 coated 96 well for 24 hrs. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the third experiment, duplicate spot#2.

source_name: Primary CD4+ T-cell, control, 24h


title: T_CON_EXP3_DUPLICATE1

description: purified DO11.10 mice splenic CD4+ T-cells without DU treatment in anti-CD3 coated 96 well for 24 hrs. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the third experiment, duplicate spot#1.


title: T_CON_EXP2_DUPLICATE2

description: purified DO11.10 mice splenic CD4+ T-cells without DU treatment in anti-CD3 coated 96 well for 24 hrs. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the second experiment, duplicate spot#2.


title: pool of a5, a6

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a5 and a6 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: T_DU_EXP1_DUPLICATE2

description: purified DO11.10 mice splenic CD4+ T-cells with 100uM DU treatment in anti-CD3 coated 96 well for 24 hrs. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the first experiment, duplicate spot#2.


title: pool of 12 a-individual rats (aliquot aq)


title: T_DU_EXP2_DUPLICATE2

description: purified DO11.10 mice splenic CD4+ T-cells with 100uM DU treatment in anti-CD3 coated 96 well for 24 hrs. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the second experiment, duplicate spot#2.


title: pool of a6, a8, a9

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a6, a8, and a9 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: individual rat a9

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a9 in diestrus.
a is RXR treatment, b is control


title: individual rat a8

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a8 in diestrus.
a is RXR treatment, b is control


title: individual rat a7

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a7 in diestrus.
a is RXR treatment, b is control


title: T_DU_EXP2_DUPLICATE1

description: purified DO11.10 mice splenic CD4+ T-cells with 100uM DU treatment in anti-CD3 coated 96 well for 24 hrs. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the second experiment, duplicate spot#1.


title: T_CON_EXP1_DUPLICATE2

description: purified DO11.10 mice splenic CD4+ T-cells without DU treatment in anti-CD3 coated 96 well for 24 hrs. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the first experiment, duplicate spot#2.


title: pool of a8, a9

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a8 and a9 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: individual rat a3, technical rep2

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: individual rat a6

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a6 in diestrus.
a is RXR treatment, b is control


title: T_CON_EXP2_DUPLICATE1

description: purified DO11.10 mice splenic CD4+ T-cells without DU treatment in anti-CD3 coated 96 well for 24 hrs. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the second experiment, duplicate spot#1.


title: T_CON_EXP1_DUPLICATE1

description: purified DO11.10 mice splenic CD4+ T-cells without DU treatment in anti-CD3 coated 96 well for 24 hrs. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the first experiment, duplicate spot#1.


title: MQ_DU_EXP3_DUPLICATE2

description: Balb/c thioglycollate-elicitated peritoneal macrophages were treated with 50uM DU for 24h. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the third experiment, duplicate spot#2.

source_name: macrophage, 50uM DU treatment, 24h


title: individual rat a3, technical rep1


title: individual rat a5

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a5 in diestrus.
a is RXR treatment, b is control


title: pool of a4, a7

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a4 and a7 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: MQ_DU_EXP3_DUPLICATE1

description: Balb/c thioglycollate-elicitated peritoneal macrophages were treated with 50uM DU for 24h. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the third experiment, duplicate spot#1.


title: MQ_DU_EXP2_DUPLICATE2

description: Balb/c thioglycollate-elicitated peritoneal macrophages were treated with 50uM DU for 24h. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the second experiment, duplicate spot#2.


title: MQ_DU_EXP2_DUPLICATE1

description: Balb/c thioglycollate-elicitated peritoneal macrophages were treated with 50uM DU for 24h. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the second experiment, duplicate spot#1.


title: individual rat a2

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a2 in estrus.
a is RXR treatment, b is control


title: individual rat a3

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a3 in proestrus or estrus.
a is RXR treatment, b is control


title: aliquot aq, technical rep1

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from the 12 individual rats in group a to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: individual rat a4

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a4 in diestrus.
a is RXR treatment, b is control


title: pool of a2, a3

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a2 and a3 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: MQ_DU_EXP1_DUPLICATE2

description: Balb/c thioglycollate-elicitated peritoneal macrophages were treated with 50uM DU for 24h. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the first experiment, duplicate spot#2.


title: MQ_CON_EXP2_DUPLICATE2

description: BALB/C THIOGLYCOLLATE-ELICITATED PERITONEAL MACROPHAGES WITHOUT DU TREATMENT FOR 24HRS. P33 LABELED CDNA PROBE HYBRIDIZE WITH ARRAY AT 55C FOR OVERNIGHT. SCAN AT 50UM RESOLUTION. THIS IS THE SECOND EXPERIMENT, DUPLICATE DOT #2

source_name: MACROPHAGE, CONTORL, 24H


title: MQ_CON_EXP2_DUPLICATE1

description: BALB/C THIOGLYCOLLATE-ELICITATED PERITONEAL MACROPHAGES WITHOUT DU TREATMENT FOR 24HRS. P33 LABELED CDNA PROBE HYBRIDIZE WITH ARRAY AT 55C FOR OVERNIGHT. SCAN AT 50UM RESOLUTION. THIS IS THE SECOND EXPERIMENT, DUPLICATE DOT #1

source_name: MACROPHAGE, CONTROL, 24H


title: individual rat a11

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a11 in estrus.
a is RXR treatment, b is control


title: pool of a12, a14, a7

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a12, a14, and a7 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: individual rat a12

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a12 in estrus.
a is RXR treatment, b is control


title: pool of a2, a3, a5

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a2, a3 and a5 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: MQ_CON_EXP3_DUPLICATE2

description: BALB/C THIOGLYCOLLATE-ELICITATED PERITONEAL MACROPHAGES WITHOUT DU TREATMENT FOR 24HRS. P33 LABELED CDNA PROBE HYBRIDIZE WITH ARRAY AT 55C FOR OVERNIGHT. SCAN AT 50UM RESOLUTION. THIS IS THE THIRD EXPERIMENT, DUPLICATE DOT #2


title: MQ_CON_EXP1_DUPLICATE2

description: BALB/C THIOGLYCOLLATE-ELICITATED PERITONEAL MACROPHAGES WITHOUT DU TREATMENT FOR 24HRS. P33 LABELED CDNA PROBE HYBRIDIZE WITH ARRAY AT 55C FOR OVERNIGHT. SCAN AT 50UM RESOLUTION. THIS IS THE FIRST EXPERIMENT, DUPLICATE DOT #2


title: MQ_DU_EXP1_DUPLICATE1

description: Balb/c thioglycollate-elicitated peritoneal macrophages were treated with 50uM DU for 24h. P33-labeled cDNA probe hybridized with array at 55C for overnight and scan at 50microron resolution. This is the first experiment, duplicate spot#1.


title: MQ_CON_EXP1_DUPLICATE1

description: BALB/C THIOGLYCOLLATE-ELICITATED PERITONEAL MACROPHAGES WITHOUT DU TREATMENT FOR 24HRS. P33 LABELED CDNA PROBE HYBRIDIZE WITH ARRAY AT 55C FOR OVERNIGHT. SCAN AT 50UM RESOLUTION.


title: individual rat a10

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a10 in proestrus.
a is RXR treatment, b is control


title: MQ_CON_EXP3_DUPLICATE1

description: BALB/C THIOGLYCOLLATE-ELICITATED PERITONEAL MACROPHAGES WITHOUT DU TREATMENT FOR 24HRS. P33 LABELED CDNA PROBE HYBRIDIZE WITH ARRAY AT 55C FOR OVERNIGHT. SCAN AT 50UM RESOLUTION. THIS IS THE THIRD EXPERIMENT, DUPLICATE DOT #1


title: individual rat a14

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Hybridization used 10 mu g of the fragmented cRNA targets. Individual rat a14 in proestrus or estrus.
a is RXR treatment, b is control


title: pool of a10, a11, a4

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a10, a11, and a4 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: pool of a12, a14

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a12 and a14 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: pool of a10, a11

description:
total RNA was extracted from individual rat mammary glands; 5 mu g of each RNA sample was reverse transcribed, synthesized to double-stranded cDNA, and then transcribed to biotin-labeled cRNA targets which were then fragmented. Equal amounts of fragmented targets were combined from individual rats a10 and a11 to give a total of 10 mu g of the fragmented cRNA targets.
a is RXR treatment, b is control


title: 9838184

status: Public on Feb 24 2005

city: Boston

first: Wenzhong Xiao

address: 55 Fruit Street, GRV 1302

department: Department of Surgery

institute: Massachusetts General Hospital

description: T Cell and monocyte populations, leukocyte or leukocyte subpopulations

source_name: blood


title: 6505504


title: 3650441


title: 4155237


title: 34311726


title: 8422169


title: 7281490


title: 5512214


title: 33995377


title: 3419837


title: 31456698


title: 26397775


title: 29623242


title: 28017026


title: 28275580


title: 28415673


title: 25767845


title: 27643110


title: 28693966


title: 27680978


title: 26933506


title: 2902223


title: 27583737


title: 23318327


title: 2552294


title: 26552433


title: 21626516


title: 20452716


title: 2386342


title: 19204721


title: 1413888


title: 19838868


title: 13888388


title: 11839063


title: 13409859


title: 22180940


title: 11860475


title: 11281647


title: 11755979


title: Chip C PKCi

status: Public on Feb 23 2005

city: Baltimore

first: Michael

middle: A

last: Lutz

department: Oncology

institute: Johns Hopkins

description: pooled mRNA (2, 4, 6 hrs) from anti-TCR + PKC inhibitor stimulated A.E7 T cells

source_name: AE.7 T cells


title: Chip B Combo

description: pooled mRNA (2, 4, 6 hrs) from anti-TCR + Rapamycin + PD98059 + SB203580 stimulated A.E7 T cells

source_name: A.E7 T cells


title: Chip B Anergic

description: pooled mRNA (2, 4, 6 hrs) from anti-TCR stimulated A.E7 T cells


title: Chip C Combo


title: Chip B Mock

description: pooled mRNA (2, 4, 6 hrs) from mock stimulated A.E7 T cells


title: Chip B CSA

description: pooled mRNA (2, 4, 6 hrs) from anti-TCR + CSA stimulated A.E7 T cells


title: 33309742


title: 1080955


title: 10906948


title: Chip C Mock


title: Chip C Anergic


title: Chip A Combo


title: Chip B PKCi


title: Chip C CSA


title: 16681670


title: 16607378


title: Chip A PKCi


title: 10787477


title: Chip A CSA


title: Chip A Mock


title: Chip A Anergic


city: Oklahoma City

first: Stewart

middle: Alan

last: Shields

state: OK

address: 825 NE 13th St

department: Arthritis/Immunology

institute: Oklahoma Medical Research Foundation

description:
normal human bronchial epithelial (NHBE), 4 hr replicate 2 15 min smoke ( experiment SE76 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


title: Src-specific_repeat_basal

city: Grand Rapids

first: Paul

last: Bromann

state: MI

address: 333 Bostwick Avenue, NE

department: Signal Regulation and Cancer

institute: Van Andel Research Institute

description: This experiment was performed to identify immediate early genes that were induced by PDGF through Src family kinases (SFKs). This particular sample is from vehicle-treated quiescent NIH 3T3 cells and represents the reference sample for this series.

source_name: NIH3T3 cells


title: Src-specific_repeat_PDGF+Src-inhibitor

description: This experiment was performed to identify immediate early genes that were induced by PDGF through Src family kinases (SFKs). This particular sample is from quiescent NIH 3T3 cells treated for 1 hour with 25 ng/ml PDGF in the presence of 2 micromolar SU6656.


description:
normal human bronchial epithelial (NHBE), 4 hr replicate 1 15 min smoke ( experiment SE76 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


title: Src-specific_PDGF+PI3K-inhibitor

description: This experiment was performed to identify immediate early genes that were induced by PDGF specifically through Src family kinases (SFKs), MEK1/2, or PI 3-K. This particular sample is from quiescent NIH 3T3 cells treated for 1 hour with 25 ng/ml PDGF in the presence of 7.5 micromolar LY294002.


description:
normal human bronchial epithelial (NHBE), 24 hr replicate 1 Mock ( experiment SE76 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


title: Src-specific_PDGF+MEK1/2-inhibitor

description: This experiment was performed to identify immediate early genes that were induced by PDGF specifically through Src family kinases (SFKs), MEK1/2, or PI 3-K. This particular sample is from quiescent NIH 3T3 cells treated for 1 hour with 25 ng/ml PDGF in the presence of 10 micromolar UO126.


description:
normal human bronchial epithelial (NHBE), 24 hr replicate 2 Mock ( experiment SE76 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


title: Src-specific_repeat_PDGF

description: This experiment was performed to identify immediate early genes that were induced by PDGF through Src family kinases (SFKs). This particular sample is from quiescent NIH 3T3 cells treated for 1 hour with 25 ng/ml PDGF.


description:
normal human bronchial epithelial (NHBE), 4 hr replicate 2 Mock ( experiment SE76 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


title: MEK-specific_PDGF+PD98059

description: Experiment to determine genes that are induced by 25 ng/ml PDGF and inhibited by MEK-specific inhibitors. This sample represents data from  cells treated with 25 ng/ml PDGF and 7.5 micromolar PD98059.


title: MEK-specific_PDGF+UO126

description: Experiment to determine genes that are induced by 25 ng/ml PDGF and inhibited by MEK-specific inhibitors. This sample represents data from  cells treated with 25 ng/ml PDGF and 10 micromolar UO126.


description:
normal human bronchial epithelial (NHBE), 4hr replicate 2 15 min smoke ( experiment SE 68 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


title: Src-specific_MEK1/2-inihibitor

description: This experiment was performed to identify immediate early genes that were induced by PDGF specifically through Src family kinases (SFKs), MEK1/2, or PI 3-K. This particular sample is from quiescent NIH 3T3 cells treated with 10 micromolar UO126.


title: Src-specific_Src-inihibitor

description: This experiment was performed to identify immediate early genes that were induced by PDGF specifically through Src family kinases (SFKs), MEK1/2, or PI 3-K. This particular sample is from quiescent NIH 3T3 cells treated with 2 micromolar SU6656.


description:
normal human bronchial epithelial (NHBE), 4 hr replicate 1 Mock ( experiment SE76 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


description:
normal human bronchial epithelial (NHBE), 24 hr replicate 2 15 min smoke ( experiment SE76 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


title: MEK-specific_PDGF

description: Experiment to determine genes that are induced by 25 ng/ml PDGF and inhibited by MEK-specific inhibitors. This sample represents data from  cells treated with 25 ng/ml PDGF.


description:
normal human bronchial epithelial (NHBE), 24hr replicate 1 15 min smoke ( experiment SE 68 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


description:
normal human bronchial epithelial (NHBE), 24hr replicate 3 Mock ( experiment SE 68 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


title: Src-specific_PDGF+Src-inhibitor

description: This experiment was performed to identify immediate early genes that were induced by PDGF specifically through Src family kinases (SFKs), MEK1/2, or PI 3-K. This particular sample is from quiescent NIH 3T3 cells treated for 1 hour with 25 ng/ml PDGF in the presence of 2 micromolar SU6656.


description:
normal human bronchial epithelial (NHBE), 4hr replicate 1 15 min smoke ( experiment SE 68 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


description:
normal human bronchial epithelial (NHBE), 24 hr replicate 1 15 min smoke ( experiment SE76 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


description:
normal human bronchial epithelial (NHBE), 24hr replicate 2 15 min smoke ( experiment SE 68 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


description:
normal human bronchial epithelial (NHBE), 24hr replicate 1 Mock ( experiment SE 68 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


description:
normal human bronchial epithelial (NHBE), 24hr replicate 2 Mock ( experiment SE 68 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


title: Src-specific_PDGF

description: This experiment was performed to identify immediate early genes that were induced by PDGF specifically through Src family kinases (SFKs), MEK1/2, or PI 3-K. This particular sample is from quiescent NIH 3T3 cells treated with 25 ng/ml PDGF for 1 hour.


description:
normal human bronchial epithelial (NHBE), 4hr replicate 2 Mock ( experiment SE 68 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


title: MEK-specific_UO126

description: Experiment to determine genes that are induced by 25 ng/ml PDGF and inhibited by MEK-specific inhibitors. This sample represents data from  cells treated with 10 micromolar UO126.


title: Src-specific_PI3K-inihibitor

description: This experiment was performed to identify immediate early genes that were induced by PDGF specifically through Src family kinases (SFKs), MEK1/2, or PI 3-K. This particular sample is from quiescent NIH 3T3 cells treated with 7.5 micromolar LY294002.


title: MEK-specific_PD98059

description: Experiment to determine genes that are induced by 25 ng/ml PDGF and inhibited by MEK-specific inhibitors. This sample represents data from  cells treated with 7.5 micromolar PD98059.


title: Cell Culture B chip 24 hour leg rep 2

status: Public on Feb 19 2005

city: Cleveland

first: Henry

middle: J.

last: Kaminski

state: OH

address: 11100 Euclid Avenue

department: Neurology

institute: Case Western Reserve University

description:
Standard Affymetrix Protocol
Keywords = microarray
Keywords = muscle

source_name: 24 hour mouse leg muscle


title: Cell Culture B chip 48 hour leg rep 3

source_name: 48 hour mouse leg muscle


title: MEK-specific_basal

description: Experiment to determine genes that are induced by 25 ng/ml PDGF and inhibited by MEK-specific inhibitors. This sample represents data from untreated quiescent cells.


title: Cell Culture B chip 24 hour leg rep 3


title: Cell Culture B chip 48 hour leg rep 1


title: Cell Culture B chip 4 hour leg rep 3

source_name: 4 hour mouse leg muscle


title: Cell Culture B chip 12 hour leg rep 2

source_name: 12 hour mouse leg muscle


description:
normal human bronchial epithelial (NHBE), 24hr replicate 3 15 min smoke ( experiment SE 68 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


description:
normal human bronchial epithelial (NHBE), 4hr replicate 1 Mock ( experiment SE 68 )
Keywords = cigarette smoke, microarray, bronchial cell, tobacco


title: Cell Culture B chip 48 hour EOM rep 2

source_name: 48 hour mouse extraocular muscle


title: Cell Culture B chip 4 hour leg rep 1


title: Cell Culture B chip 48 hour leg rep 2


title: Cell Culture B chip 24 hour EOM rep 3

source_name: 24 hour mouse extraocular muscle


title: Cell Culture B chip 12 hour leg rep 1


title: Cell Culture B chip 12 hour leg rep 3


title: Cell Culture B chip 48 hour EOM rep 3


title: Cell Culture B chip 0 hour leg rep 2

source_name: 0 hour mouse leg muscle


title: Cell Culture B chip 24 hour EOM rep 1


title: Cell Culture B chip 24 hour leg rep 1


title: Cell Culture B chip 0 hour leg rep 3


title: Cell Culture B chip 24 hour EOM rep 2


title: Cell Culture B chip 0 hour leg rep 1


title: Cell Culture B chip 12 hour EOM rep 3

source_name: 12 hour mouse extraocular muscle


title: Cell Culture B chip 48 hour EOM rep 1


title: Src-specific_basal

description: This experiment was performed to identify immediate early genes that were induced by PDGF specifically through Src family kinases (SFKs), MEK1/2, or PI 3-K. This particular sample is from vehicle-treated quiescent NIH 3T3 cells and represents the reference sample for this series.


title: Cell Culture B chip 4 hour leg rep 2


title: Cell Culture B chip 12 hour EOM rep 1


title: Cell Culture B chip 12 hour EOM rep 2


title: Cell Culture B chip 4 hour EOM rep 1

source_name: 4 hour mouse extraocular muscle


title: Cell Culture B chip 0 hour EOM rep 3

source_name: 0 hour mouse extraocular muscle


title: Cell Culture B chip 4 hour EOM rep 3


title: Cell Culture B chip 0 hour EOM rep 2


title: Cell Culture B chip 4 hour EOM rep 2


title: Cell Culture B chip 0 hour EOM rep 1


title: Cell Culture A chip 12 hour leg rep 3


title: Cell Culture A chip 12 hour leg rep 2


title: Cell Culture A chip 48 hour leg rep 1


title: Cell Culture A chip 48 hour leg rep 3


title: Cell Culture A chip 24 hour leg rep 2


title: Cell Culture A chip 48 hour leg rep 2


title: Cell Culture A chip 12 hour leg rep 1

source_name: 12 Hour mouse leg muscle


title: Cell Culture A chip 24 hour leg rep 3

source_name: 24 Hour mouse leg muscle


title: Cell Culture A chip 24 hour leg rep 1


title: AD

city: Aas

first: Aleksei

last: Krasnov

address: Osloveien 1

department: Fish Health

country: Norway

institute: Nofima AS

description: comparison of gene expression in atria of cold- and warm-acclimated fish

organism: Oncorhynchus mykiss

source_name: atrium from warm-acclimated fish

source_name: atrium from cold-acclimated fish


title: 15T

city: Philadelphia

first: Rebekah

middle: K

last: O'Donnell

state: PA

department: Pathology

institute: Children's Hospital of Philadelphia

description:
white male age 47, tongue, pathological T stage = 2, pathological N stage = 0
Keywords = oral carcinoma lymphatic metastasis

source_name: primary carcinoma from patient 15


title: Cell Culture A chip 4 hour leg rep 3

source_name: 4 Hour Mouse leg muscle


title: 22T

description: white male age 50, tongue, pathological T stage = 1, pathological N stage = 0

source_name: primary carcinoma from patient 22


title: AR


title: VR

description: comparison of gene expression in ventricles of cold- and warm-acclimated fish

source_name: ventricle from cold-acclimated fish

source_name: ventricle from warm-acclimated fish


title: 17T

description:
white male age 62, FOM/Tonsil, pathological T stage = 4a, pathological N stage = 0
Keywords = oral carcinoma lymphatic metastasis

source_name: primary carcinoma from patient 17


title: Cell Culture A chip 4 hour leg rep 2


title: 16T

description:
white male age 48, tongue, pathological T stage = 2, pathological N stage = 0
Keywords = oral carcinoma lymphatic metastasis

source_name: primary carcinoma from patient 16


title: 20T

description: Asian male age 56, tongue, pathological T stage = 1, pathological N stage = 2b

source_name: primary carcinoma from patient 20


title: 14T

description:
white male age 59, FOM, pathological T stage = 4a, pathological N stage = 0
Keywords = oral carcinoma lymphatic metastasis

source_name: primary carcinoma from patient 14


title: 21T

description: male age 45, larynx, pathological T stage = 3, pathological N stage = 2b

source_name: primary carcinoma from patient 21


title: VD


title: Cell Culture A chip 4 hour leg rep 1


title: 19T

description:
white male age 63, tongue, pathological T stage = 4, pathological N stage = 2b
Keywords = oral carcinoma lymphatic metastasis

source_name: primary carcinoma from patient 19


title: Cell Culture A chip 0 hour leg rep 2

source_name: 0 Hour Mouse leg muscle


title: 12T

description:
white male age 59, tongue, pathological T stage = 3, pathological N stage = 0
Keywords = oral carcinoma lymphatic metastasis

source_name: primary carcinoma from patient 12


title: 18T

description:
white male age 51, tongue, pathological T stage = 1, pathological N stage = 0
Keywords = oral carcinoma lymphatic metastasis

source_name: primary carcinoma from patient 18


title: 13T

description:
white male age 83, FOM, pathological T stage = 4a, pathological N stage = 0
Keywords = oral carcinoma lymphatic metastasis

source_name: primary carcinoma from patient 13


title: Cell Culture A chip 48 hour EOM rep 3

description:
Standard Affymetrix Protocol
Keywords = microarray
Keywords = muscle

source_name: 48 Hour Mouse extraocular muscle


title: Cell Culture A chip 48 hour EOM rep 1


title: Cell Culture A chip 48 hour EOM rep 2


title: Cell Culture A chip 0 hour leg rep 1


title: Cell Culture A chip 0 hour leg rep 3


title: 8T

description:
white male age 59, tongue, pathological T stage = 3, pathological N stage = 2
Keywords = oral carcinoma lymphatic metastasis

source_name: primary carcinoma from patient 8


title: 11T

description:
white male age 69, tongue, pathological T stage = 1, pathological N stage = 2
Keywords = oral carcinoma lymphatic metastasis

source_name: primary carcinoma from patient 11


title: 4T

description:
male age 80, FOM/Buccal, pathological T stage = 4a, pathological N stage = 1
Keywords = oral carcinoma lymphatic metastasis

source_name: primary carcinoma from patient 4


title: Cell Culture A chip 24 hour EOM rep 1

source_name: 24 Hour Mouse extraocular muscle


title: 10T

description:
white female age 75, tongue, pathological T stage = 2, pathological N stage = 2
Keywords = oral carcinoma lymphatic metastasis

source_name: primary carcinoma from patient 10


title: Cell Culture A chip 24 hour EOM rep 2


title: 9T

description:
white male age 76, tongue, pathological T stage = 2, pathological N stage = 1
Keywords = oral carcinoma lymphatic metastasis

source_name: primary carcinoma from patient 9


title: Cell Culture A chip 12 hour EOM rep 3

source_name: 12 Hour Mouse extraocular muscle


title: 7T

description:
black male age 80, gingiva, pathological T stage = 4a, pathological N stage = 2b
Keywords = oral carcinoma lymphatic metastasis

source_name: primary carcinoma from patient 7


title: Cell Culture A chip 24 hour EOM rep 3


title: Cell Culture A chip 12 hour EOM rep 1


title: 10N

source_name: lymph node metastasis from patient 10


title: 6T

description:
black female age 47, tongue, pathological T stage = 4a, pathological N stage = 2b
Keywords = oral carcinoma lymphatic metastasis

source_name: primary carcinoma from patient 6


title: 3T

description:
white male age 42, mandible, pathological T stage = 4a, pathological N stage = 2
Keywords = oral carcinoma lymphatic metastasis

source_name: primary carcinoma from patient 3


title: 2N

description:
white female age 47, tongue, pathological T stage = 2, pathological N stage = 2
Keywords = oral carcinoma lymphatic metastasis

source_name: lymph node metastasis of patient 2


title: Cell Culture A chip 4 hour EOM rep 3

source_name: 4 Hour Mouse extraocular muscle


title: Cell Culture A chip 4 hour EOM rep 2


title: Cell Culture A chip 4 hour EOM rep 1


title: 3N

source_name: lymph node metastasis of patient 3


title: 4N

source_name: lymph node metastasis of patient 4


title: Cell Culture A chip 12 hour EOM rep 2


title: Cell Culture A chip 0 hour EOM rep 3

source_name: 0 Hour Mouse extraocular muscle


title: 1N

description:
white male age 76, mandible, pathological T stage = 3, pathological N stage = 2c
Keywords = oral carcinoma lymphatic metastasis

source_name: lymph node metastasis of patient 1


title: 1T

source_name: primary carcinoma from patient 1


title: 2T

source_name: primary carcinoma from patient 2


title: Titanium Dioxide vs. Mouse Reference

status: Public on Feb 18 2005

city: Missoula

first: Corbin

last: Schwanke

state: MT

department: Biomedical and Pharmaceutical Sciences

institute: University of Montana

description: cDNA produced from Universal Mouse Reference RNA lot #0810729 indirectly labeled with Molecular Probes Alexa-Fluor 532 hybridized with cDNA produced from amplifed mRNA (Arcturus RiboAmp) from mouse broncho-alveolar lavages. Mice were intranasally instilled with 30 ul suspensions of 500 ug of TiO2 in saline solution at 6 weeks of age and macrophages were harvested by alveolar lavage at 14 weeks. RNA was isolated by RNeasy extraction (Qiagen)

source_name: Stratagene Universal Mouse Reference RNA

source_name: aRNA from broncho-alveolar lavage samples


title: Cell Culture A chip 0 hour EOM rep 2

source_name: 0 hour Mouse extraocular muscle


title: Silica vs. Mouse Reference

description: cDNA produced from Universal Mouse Reference RNA lot #0810729 indirectly labeled with Molecular Probes Alexa-Fluor 532 hybridized with cDNA produced from amplifed mRNA (Arcturus RiboAmp) from mouse broncho-alveolar lavages. Mice were intranasally instilled with 30 ul suspensions of 1mg of crystalline silica in saline solution at 6 weeks of age and macrophages were harvested by alveolar lavage at 14 weeks. RNA was isolated by RNeasy extraction (Qiagen)


title: Cell Culture A chip 0 hour EOM rep 1


title: MEL1Cy5A

city: Miami

first: andrew

last: whitehead

institute: University of Miami, RSMAS

description: Samples were from one of three populations (ME for Maine, NJ for New Jersey, and GA for Georgia), and from one of three tissues (L for liver, H for heart, and B for brain).  There were three replicate individuals per population-tissue (1, 2, or 3).  So in total there were 27 samples.  Each sample was hybridized 4 times - twice labeled with Cy3 ("Cy3A" or "Cy3B") and twice with Cy5 ("Cy5A" or "Cy5B").

organism: Fundulus heteroclitus

source_name: Maine, liver, replicate individual 1, labeled with Cy5


title: NJL3Cy5A

source_name: New Jersey, liver, replicate individual 3, labeled with Cy5


title: GAL2Cy5A

source_name: Georgia, liver, replicate individual 2, labeled with Cy5


title: NJH3Cy5A

source_name: New Jersey, heart, replicate individual 3, labeled with Cy5


title: MEH3Cy5B

source_name: Maine, heart, replicate individual 3, labeled with Cy5


title: NJB3Cy3B

source_name: New Jersey, brain, replicate individual 3, labeled with Cy3


title: NJH3Cy3B

source_name: New Jersey, heart, replicate individual 3, labeled with Cy3


title: GAH2Cy3B

source_name: Georgia, heart, replicate individual 2, labeled with Cy3


title: MEH3Cy3A

source_name: Maine, heart, replicate individual 3, labeled with Cy3


title: GAH2Cy5A

source_name: Georgia, heart, replicate individual 2, labeled with Cy5


title: NJL3Cy3A

source_name: New Jersey, liver, replicate individual 3, labeled with Cy3


title: GAB2Cy5B

source_name: Georgia, brain, replicate individual 2, labeled with Cy5


title: GAH3Cy3A

source_name: Georgia, heart, replicate individual 3, labeled with Cy3


title: Saline vs. Mouse Reference

description: cDNA produced from Universal Mouse Reference RNA lot #0810729 indirectly labeled with Molecular Probes Alexa-Fluor 532 hybridized with cDNA produced from amplifed mRNA (Arcturus RiboAmp) from mouse broncho-alveolar lavages.  Mice were intranasally instilled with 30 ul of saline solution at 6 weeks of age and macrophages were harvested by alveolar lavage at 14 weeks.  RNA was isolated by RNeasy extraction (Qiagen)


title: GAB2Cy3B

source_name: Georgia, brain, replicate individual 2, labeled with Cy3


title: GAH3Cy5B

source_name: Georgia, heart, replicate individual 3, labeled with Cy5


title: NJH2Cy5B

source_name: New Jersey, heart, replicate individual 2, labeled with Cy5


title: MEH2Cy3B

source_name: Maine, heart, replicate individual 2, labeled with Cy3


title: MEL2Cy3A

source_name: Maine, liver, replicate individual 2, labeled with Cy3


title: NJH2Cy3A

source_name: New Jersey, heart, replicate individual 2, labeled with Cy3


title: MEL2Cy5A

source_name: Maine, liver, replicate individual 2, labeled with Cy5


title: GAL2Cy3A

source_name: Georgia, liver, replicate individual 2, labeled with Cy3


title: NJB3Cy5B

source_name: New Jersey, brain, replicate individual 3, labeled with Cy5


title: MEH2Cy5A

source_name: Maine, heart, replicate individual 2, labeled with Cy5


title: MEB2Cy5B

source_name: Maine, brain, replicate individual 2, labeled with Cy5


title: MEB2Cy3B

source_name: Maine, brain, replicate individual 2, labeled with Cy3


title: GAH1Cy5B

source_name: Georgia, heart, replicate individual 1, labeled with Cy5


title: GAB3Cy3B

source_name: Georgia, brain, replicate individual 3, labeled with Cy3


title: NJL1Cy5A

source_name: New Jersey, liver, replicate individual 1, labeled with Cy5


title: GAH1Cy3A

source_name: Georgia, heart, replicate individual 1, labeled with Cy3


title: NJH1Cy3B

source_name: New Jersey, heart, replicate individual 1, labeled with Cy3


title: NJB1Cy5B

source_name: New Jersey, brain, replicate individual 1, labeled with Cy5


title: MEH1Cy3A

source_name: Maine, heart, replicate individual 1, labeled with Cy3


title: NJH1Cy5A

source_name: New Jersey, heart, replicate individual 1, labeled with Cy5


title: GAH3Cy5A

source_name: Georgia, heart, replicate individual 3, labeled with Cy5


title: GAL3Cy3B

source_name: Georgia, liver, replicate individual 3, labeled with Cy3


title: GAB3Cy5A

source_name: Georgia, brain, replicate individual 3, labeled with Cy5


title: NJH3Cy3A

source_name: New Jersey, heart, replicate individual 3, labeled with Cy3


title: MEH1Cy5B

source_name: Maine, heart, replicate individual 1, labeled with Cy5


title: MEB3Cy3A

source_name: Maine, brain, replicate individual 3, labeled with Cy3


title: NJB1Cy3B

source_name: New Jersey, brain, replicate individual 1, labeled with Cy3


title: MEH3Cy5A

source_name: Maine, heart, replicate individual 3, labeled with Cy5


title: MEH3Cy3B

source_name: Maine, heart, replicate individual 3, labeled with Cy3


title: GAH2Cy5B

source_name: Georgia, heart, replicate individual 2, labeled with Cy5


title: MEB3Cy5A

source_name: Maine, brain, replicate individual 3, labeled with Cy5


title: GAH3Cy3B

source_name: Georgia, heart, replicate individual 3, labeled with Cy3


title: GAL3Cy5B

source_name: Georgia, liver, replicate individual 3, labeled with Cy5


title: NJH3Cy5B

source_name: New Jersey, heart, replicate individual 3, labeled with Cy5


title: MEL3Cy5B

source_name: Maine, liver, replicate individual 3, labeled with Cy5


title: MEL3Cy3B

source_name: Maine, liver, replicate individual 3, labeled with Cy3


title: GAH2Cy3A

source_name: Georgia, heart, replicate individual 2, labeled with Cy3


title: NJB2Cy5A

source_name: New Jersey, brain, replicate individual 2, labeled with Cy5


title: NJH2Cy3B

source_name: New Jersey, heart, replicate individual 2, labeled with Cy3


title: NJL2Cy3B

source_name: New Jersey, liver, replicate individual 2, labeled with Cy3


title: NJL2Cy5B

source_name: New Jersey, liver, replicate individual 2, labeled with Cy5


title: NJB2Cy3A

source_name: New Jersey, brain, replicate individual 2, labeled with Cy3


title: GAL1Cy3B

source_name: Georgia, liver, replicate individual 1, labeled with Cy3


title: GAB1Cy5A

source_name: Georgia, brain, replicate individual 1, labeled with Cy5


title: MEH2Cy3A

source_name: Maine, heart, replicate individual 2, labeled with Cy3


title: MEH2Cy5B

source_name: Maine, heart, replicate individual 2, labeled with Cy5


title: NJL1Cy3A

source_name: New Jersey, liver, replicate individual 1, labeled with Cy3


title: GAL1Cy5B

source_name: Georgia, liver, replicate individual 1, labeled with Cy5


title: GAH1Cy3B

source_name: Georgia, heart, replicate individual 1, labeled with Cy3


title: NJH1Cy3A

source_name: New Jersey, heart, replicate individual 1, labeled with Cy3


title: GAB1Cy3A

source_name: Georgia, brain, replicate individual 1, labeled with Cy3


title: NJH1Cy5B

source_name: New Jersey, heart, replicate individual 1, labeled with Cy5


title: MEH1Cy5A

source_name: Maine, heart, replicate individual 1, labeled with Cy5


title: MEL1Cy5B

source_name: Maine, liver, replicate individual 1, labeled with Cy5


title: MEB1Cy3A

source_name: Maine, brain, replicate individual 1, labeled with Cy3


title: MEB3Cy3B

source_name: Maine, brain, replicate individual 3, labeled with Cy3


title: GAB3Cy3A

source_name: Georgia, brain, replicate individual 3, labeled with Cy3


title: NJL3Cy5B

source_name: New Jersey, liver, replicate individual 3, labeled with Cy5


title: NJL3Cy3B

source_name: New Jersey, liver, replicate individual 3, labeled with Cy3


title: GAB3Cy5B

source_name: Georgia, brain, replicate individual 3, labeled with Cy5


title: NJH2Cy5A

source_name: New Jersey, heart, replicate individual 2, labeled with Cy5


title: MEL1Cy3B

source_name: Maine, liver, replicate individual 1, labeled with Cy3


title: MEH1Cy3B

source_name: Maine, heart, replicate individual 1, labeled with Cy3


title: MEB3Cy5B

source_name: Maine, brain, replicate individual 3, labeled with Cy5


title: GAL2Cy3B

source_name: Georgia, liver, replicate individual 2, labeled with Cy3


title: GAL2Cy5B

source_name: Georgia, liver, replicate individual 2, labeled with Cy5


title: MEB1Cy5A

source_name: Maine, brain, replicate individual 1, labeled with Cy5


title: NJB2Cy3B

source_name: New Jersey, brain, replicate individual 2, labeled with Cy3


title: NJB2Cy5B

source_name: New Jersey, brain, replicate individual 2, labeled with Cy5


title: MEL2Cy3B

source_name: Maine, liver, replicate individual 2, labeled with Cy3


title: GAB1Cy3B

source_name: Georgia, brain, replicate individual 1, labeled with Cy3


title: NJL1Cy3B

source_name: New Jersey, liver, replicate individual 1, labeled with Cy3


title: MEB1Cy3B

source_name: Maine, brain, replicate individual 1, labeled with Cy3


title: NJB3Cy5A

source_name: New Jersey, brain, replicate individual 3, labeled with Cy5


title: NJL1Cy5B

source_name: New Jersey, liver, replicate individual 1, labeled with Cy5


title: GAB1Cy5B

source_name: Georgia, brain, replicate individual 1, labeled with Cy5


title: MEL2Cy5B

source_name: Maine, liver, replicate individual 2, labeled with Cy5


title: MEB1Cy5B


title: MEL3Cy3A

source_name: Maine, liver, replicate individual 3, labeled with Cy3


title: GAL3Cy5A

source_name: Georgia, liver, replicate individual 3, labeled with Cy5


title: MEB2Cy5A

source_name: Maine, brain, replicate individual 2, labeled with Cy5


title: NJL2Cy5A

source_name: New Jersey, liver, replicate individual 2, labeled with Cy5


title: MEB2Cy3A

source_name: Maine, brain, replicate individual 2, labeled with Cy3


title: MEL3Cy5A

source_name: Maine, liver, replicate individual 3, labeled with Cy5


title: GAB2Cy3A

source_name: Georgia, brain, replicate individual 2, labeled with Cy3


title: asthma_OVA24h_EP3agonist_3

city: Kyoto

first: Eri

last: Segi-Nishida

country: Japan

institute: Kyoto University

description: OVA-induced asthma model:OVA challenged and agonist of PGE receptor EP3 subtype treated  #3


title: GAB2Cy5A

source_name: Georgia, brain, replicate individual 2, labeled with Cy5


title: NJB3Cy3A

source_name: New Jersey, brain, replicate individual 3, labeled with Cy3


title: GAL3Cy3A

source_name: Georgia, liver, replicate individual 3, labeled with Cy3


title: NJL2Cy3A

source_name: New Jersey, liver, replicate individual 2, labeled with Cy3


title: asthma_OVA24h_EP3agonist_2

description: OVA-induced asthma model:OVA challenged and agonist of PGE receptor EP3 subtype treated  #2


title: GAL1Cy5A

source_name: Georgia, liver, replicate individual 1, labeled with Cy5


title: NJB1Cy3A

source_name: New Jersey, brain, replicate individual 1, labeled with Cy3


title: GAL1Cy3A

source_name: Georgia, liver, replicate individual 1, labeled with Cy3


title: asthma_OVA24h_3

description: OVA-induced asthma model:OVA challenged #3


title: asthma_OVA24h_2

description: OVA-induced asthma model:OVA challenged #2


title: MEL1Cy3A

source_name: Maine, liver, replicate individual 1, labeled with Cy3


title: THsp_x_E_70853

status: Public on Feb 17 2005

state: MA

description:
spleen in mice
subjected to trauma-hemmorage injury
The Inflammation and Host Response to Injury Large Scale Collaborative Research Program

source_name: spleen


title: NJB1Cy5A

source_name: New Jersey, brain, replicate individual 1, labeled with Cy5


title: THsp_c_E_70847


title: 5T

description:
white female age 43, tongue, pathological T stage = 2, pathological N stage = 2
Keywords = oral carcinoma lymphatic metastasis

source_name: primary carcinoma from patient 5


title: asthma_saline_3

description: OVA-induced asthma model:saline challenged #3


title: asthma_OVA24h_1

description: OVA-induced asthma model:OVA challenged #1


title: asthma_saline_1

description: OVA-induced asthma model:saline challenged #1


title: THsp_x_E_70852


title: asthma_saline_2

description: OVA-induced asthma model:saline challenged #2


title: THsp_c_E_70849


title: THsp_x_E_70851


title: THsp_x_E_70854


title: THsp_c_E_70845


title: THsp_c_E_70848


title: THsp_c_E_70846


title: LPSsp_v2_x_E_122544

description:
spleen from mice subjected to lipopolysaccharide infusion
The Inflammation and Host Response to Injury Large Scale Collaborative Research Program


title: LPSsp_v2_x_E_122545


title: LPSsp_v2_x_E_122549


title: LPSsp_v2_x_E_122550


title: LPSsp_v2_x_E_122551


title: THsp_x_E_70855


title: THsp_c_E_70844


title: LPSsp_v2_x_E_122543


title: LPSsp_v2_c_E_122552


title: LPSsp_v2_c_E_122554


title: LPSsp_v2_c_E_122548


title: LPSsp_v2_c_E_122547


title: LPSsp_v2_c_E_122553


title: LPSsp_v2_c_E_122546


title: BURNsp_x_E_70824

description:
leukocytes from spleen in mice
subjected to burn injury
The Inflammation and Host Response to Injury Large Scale Collaborative Research Program


title: BURNsp_x_E_70822


title: BURNsp_x_E_70821


title: BURNsp_x_E_70825


title: BURNsp_x_E_70823


title: BURNsp_c_E_70826


title: BURNsp_c_E_70829


title: THx_A_70692

description:
leukocytes from blood (WBCs) in mice
subjected to trauma-hemmorage (title noted with E) or sham (title noted with A)
The Inflammation and Host Response to Injury Large Scale Collaborative Research Program

source_name: blood (WBCs)


title: BURNsp_c_E_70828


title: THx_E_70686


title: BURNsp_c_E_70830


title: THx_A_70691


title: THx_E_70698


title: THx_E_70687


title: THx_E_70699


title: BURNsp_x_E_70820


title: THx_E_70685


title: THx_A_70679


title: THx_E_70697


title: BURNsp_c_E_70827


title: THx_A_70693


title: THc_E_70702


title: THc_E_70689


title: THx_A_70680


title: THc_E_70701


title: THc_E_70700


title: THc_E_70690


title: THc_E_70688


title: GAH1Cy5A

source_name: Georgia, heart, replicate individual 1, labeled with Cy5


title: THc_A_70684


title: THc_A_70683


title: LPSx_E_70720

description:
leukocytes from blood (WBCs)
lipopolysaccharide infusion (title noted with E) or sham (title noted with A)
The Inflammation and Host Response to Injury Large Scale Collaborative Research Program


title: LPSx_E_70706


title: LPSx_E_70719


title: LPSc_E_70713


title: THc_A_70696


title: LPSx_E_70707


title: LPSc_A_70722


title: LPSx_A_70717


title: LPSx_E_70708


title: THc_A_70695


title: LPSc_E_70726


title: THc_A_70694


title: LPSx_A_70716


title: LPSx_A_70704


title: LPSx_A_70715


title: LPSx_A_70705


title: LPSc_A_70723


title: LPSc_E_70725


title: LPSc_E_70712


title: LPSc_E_70714


title: LPSc_A_70709


title: LPSc_E_70724


title: LPSc_A_70721


title: LPSc_A_70710


title: BURNx_E_70750

description:
leukocytes from blood (WBCs)
burn injury (title contains E) or sham (title contains A)
The Inflammation and Host Response to Injury Large Scale Collaborative Research Program


title: LPSc_A_70711


title: BURNx_E_70738


title: BURNx_E_70748


title: BURNx_A_70734


title: BURNx_E_70736


title: BURNx_A_70735


title: BURNx_A_70733


title: BURNx_A_70746


title: BURNc_E_70743


title: BURNx_E_70737


title: BURNc_E_70731


title: BURNc_A_70739


title: BURNc_E_70730


title: BURNc_A_70729


title: BURNc_E_70742


title: BURNc_A_70728


title: BURNc_E_70744


title: BURNc_E_70732


title: BURNc_A_70741


title: L180R

status: Public on Feb 16 2005

description: Late onset of M74 disease in Atlantic salmon, clinical stage, river Simojoki, reverse

organism: Salmo salar

source_name: disease

source_name: control


title: I250D

description: Intermediate onset of M74 disease in Atlantic salmon, early stage, river  Simojoki, direct


title: L50D

description: Late onset of M74 disease in Atlantic salmon, preclinical stage, river Simojoki, direct


title: L50R

description: Late onset of M74 disease in Atlantic salmon, preclinical stage, river Simojoki, reverse


title: I3TR

description: Intermediate onset of M74 disease in Atlantic salmon, terminal stage, rivers  Simojoki and Tornionjoki, reverse


title: L180D

description: Late onset of M74 disease in Atlantic salmon, clinical stage, river Simojoki, direct


title: I3TD

description: Intermediate onset of M74 disease in Atlantic salmon, terminal stage, rivers  Simojoki and Tornionjoki, direct

source_name: reverse


title: I350D

description: Intermediate onset of M74 disease in Atlantic salmon, early stage, rivers  Simojoki and Tornionjoki, direct


title: I2TR

description: Intermediate onset of M74 disease in Atlantic salmon, terminal stage, river  Simojoki, reverse


title: I350R

description: Intermediate onset of M74 disease in Atlantic salmon, early stage, rivers  Simojoki and Tornionjoki, reverse


title: I250R

description: Intermediate onset of M74 disease in Atlantic salmon, early stage, river  Simojoki, reverse


title: BURNc_A_70727


title: I1TD

description: Intermediate onset of M74 disease in Atlantic salmon, terminal stage, river Tornionjoki, direct


title: I1TR

description: Intermediate onset of M74 disease in Atlantic salmon, terminal stage, river Tornionjoki, reverse


title: E50R

description: Early onset of M74 disease in Atlantic salmon, clinical stage, river Simojoki, reverse


title: I150R

description: Intermediate onset of M74 disease in Atlantic salmon, preclinical stage, river Tornionjoki, reverse


title: I2TD

description: Intermediate onset of M74 disease in Atlantic salmon, terminal stage, river  Simojoki, direct


title: I150D

description: Intermediate onset of M74 disease in Atlantic salmon, preclinical stage, river Tornionjoki, direct


title: ETR

description: Early onset of M74 disease in Atlantic salmon, terminal stage, river Simojoki, reverse


title: ETD

description: Early onset of M74 disease in Atlantic salmon, terminal stage, river Simojoki, direct


title: E50D

description: Early onset of M74 disease in Atlantic salmon, clinical stage, river Simojoki, direct


title: lens487

status: Public on Feb 15 2005

first: Valery

middle: I.

last: Shestopalov

department: Ophtalmology

institute: University of Miami

description:
Lenses were removed and immediately fixed using 4% paraformaldehide or methanol-based UMFIX reagent (Sakura Finetek USA, Inc.). To map the exact location of both elongating and maturing fibers on the lens slices, lenses were vibratome-sliced (Vibratome 1000, St. Louis, MO) as described previously and the GFP expression pattern was captured by confocal microscopy. For RNA extraction lens tissue was sliced into 5 micron-thick paraffin sections and microdissected using LCM (Leica Microsystems, Bannockburn, IL). The mid-saggital slices were used both for syncytium border measurements and for LCM. Control measurement (data not shown) confirmed that similar rates of shrinkage in paraformaldehyde- and UMFIX-fixed samples did not affect precision of LCM dissection.
Keywords = mouse
Keywords = lens
Keywords = eye
Keywords = fiber cells

source_name: Mature fiber cells from the lens of mice (strain TgN(GFPU)5Nagy (Jackson Laboratory, Bar Harbor, ME))

source_name: Elongating fiber cells from the lens of mice (strain TgN(GFPU)5Nagy (Jackson Laboratory, Bar Harbor, ME))


title: Lens Cortical Fiber Cell (Array 3)

city: Rochester

first: John

last: Hawse

state: MN

address: 200 1st St. SW

department: Biochemistry and Molecular Biology

institute: Mayo Clinic

description: Raw Affymetrix microarray data for human lens cortical fiber cell RNA sample 3.

source_name: Human lens cortical fiber cells


title: Lens Cortical Fiber Cells (Array 2)

description: Raw Affymetrix microarray data for human lens cortical fiber cell RNA sample 2.


title: lens488


title: Lens Epithelial Cells (Array 1)

description: Raw Affymetrix microarray data for human lens epithelial cell RNA sample 1.

source_name: Human lens epithelial cells


title: Lens Epithelial Cells (Array 3)

description: Raw Affymetrix microarray data for human lens epithelial cell RNA sample 3.


title: liverA2.2: A/J liver time 2

status: Public on Feb 12 2005

city: Montreal

first: Peter

last: Lee

state: QC

address: 740 Dr Penfield

department: Dept of Human Genetics

country: Canada

institute: McGill University

description:
RNA was extracted from tissue rapidly dissected and homogenized in Trizol reagent. Targets were produced using standard Affymetrix procedures from about 20ug of total RNA.  3 biological replicates (3-month old male littermates) were analyzed for each tissue at each time.
This sample is also known as liverA2.2, celfile YF040302MGA03.CEL
Keywords = Mouse, Mus musculus, heart, A/J, C57BL/6J

source_name: liver


title: spleenA1.1: A/J spleen time 1

description:
RNA was extracted from tissue rapidly dissected and homogenized in Trizol reagent. Targets were produced using standard Affymetrix procedures from about 20ug of total RNA.  3 biological replicates (3-month old male littermates) were analyzed for each tissue at each time.
This sample is also known as spleenA1.1, celfile RS010930MU14aa.CEL
Keywords = Mouse, Mus musculus, heart, A/J, C57BL/6J


title: lens455

state: FL


title: liverB2.1: C57BL/6J liver time 2

description:
RNA was extracted from tissue rapidly dissected and homogenized in Trizol reagent. Targets were produced using standard Affymetrix procedures from about 20ug of total RNA.  3 biological replicates (3-month old male littermates) were analyzed for each tissue at each time.
This sample is also known as liverB2.1, celfile YF040302MGA02.CEL
Keywords = Mouse, Mus musculus, heart, A/J, C57BL/6J


title: heartB2.1: C57BL/6J heart time 2

description:
RNA was extracted from tissue rapidly dissected and homogenized in Trizol reagent. Targets were produced using standard Affymetrix procedures from about 20ug of total RNA.  3 biological replicates (3-month old male littermates) were analyzed for each tissue at each time.
This sample is also known as heartB2.1, celfile YF040302MGA20.CEL
Keywords = Mouse, Mus musculus, heart, A/J, C57BL/6J

source_name: heart


title: lens493


title: heartA1.2: A/J heart time 1

description:
RNA was extracted from tissue rapidly dissected and homogenized in Trizol reagent. Targets were produced using standard Affymetrix procedures from about 20ug of total RNA.  3 biological replicates (3-month old male littermates) were analyzed for each tissue at each time.
This sample is also known as heartA1.2, celfile AS020516MGA11aa.CEL
Keywords = Mouse, Mus musculus, heart, A/J, C57BL/6J


title: heartB2.3: C57BL/6J heart time 2

description:
RNA was extracted from tissue rapidly dissected and homogenized in Trizol reagent. Targets were produced using standard Affymetrix procedures from about 20ug of total RNA.  3 biological replicates (3-month old male littermates) were analyzed for each tissue at each time.
This sample is also known as heartB2.3, celfile YF040302MGA24.CEL
Keywords = Mouse, Mus musculus, heart, A/J, C57BL/6J


title: liverA1.3: A/J liver time 1

description:
RNA was extracted from tissue rapidly dissected and homogenized in Trizol reagent. Targets were produced using standard Affymetrix procedures from about 20ug of total RNA.  3 biological replicates (3-month old male littermates) were analyzed for each tissue at each time.
This sample is also known as liverA1.3, celfile RS010929MU12aa.CEL
Keywords = Mouse, Mus musculus, heart, A/J, C57BL/6J